In fact, while a number of cancer cells show ERK- and FCHSD2-dependent upregulation of endocytosis, in non-small-cell lung cancer (NSCLC) loss of function of FCHSD2 has been suggested to promote cell proliferation and migration [27]. The gene discussed is FCHSD2; the disease is non-small cell lung carcinoma.